StockData
Artelo Biosciences, Inc. logo

Artelo Biosciences, Inc. (ARTL) stock

ARTLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$1.50−0.18 (-10.71%)

Close on Nov 18, 2026Market cap $1.01MP/E –Yield –

Artelo Biosciences operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Artelo Biosciences's operating cash flow for the twelve months ending Jun 30, 2026 was -$12.63M. For fiscal 2025 it was -$8.52M. The highest annual figure on record is -$13.50K in fiscal 2015.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$8.52M–
FY2024Dec 31, 2024-$8.35M–
FY2023Dec 31, 2023-$8.21M–
FY2021Aug 31, 2021-$6.14M–
FY2020Aug 31, 2020-$4.35M–
FY2019Aug 31, 2019-$2.79M–
FY2018Aug 31, 2018-$1.61M–
FY2017Aug 31, 2017-$216.82K–
FY2016Aug 31, 2016-$18.49K–
FY2015Aug 31, 2015-$13.50K–
FY2014Aug 31, 2014-$15.27K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026-$5.03M–
Q1 FY2026CQ1 2026Mar 31, 2026-$1.19M–
Q4 FY2025CQ4 2025Dec 31, 2025-$2.91M–
Q3 FY2025CQ3 2025Sep 30, 2025-$3.50M–
Q2 FY2025CQ2 2025Jun 30, 2025-$514.00K–
Q1 FY2025CQ1 2025Mar 31, 2025-$1.60M–
Q4 FY2024CQ4 2024Dec 31, 2024-$2.57M–
Q3 FY2024CQ3 2024Sep 30, 2024-$778.00K–
Q2 FY2024CQ2 2024Jun 30, 2024-$2.06M–
Q1 FY2024CQ1 2024Mar 31, 2024-$2.94M–
Q4 FY2023CQ4 2023Dec 31, 2023-$2.60M–
Q3 FY2023CQ3 2023Sep 30, 2023-$1.80M–
Q2 FY2023CQ2 2023Jun 30, 2023-$1.62M–
Q1 FY2023CQ1 2023Mar 31, 2023-$2.19M–
Q4 FY2021CQ3 2021Aug 31, 2021-$1.54M–
Q3 FY2021CQ2 2021May 31, 2021-$1.78M–
Q2 FY2021CQ1 2021Feb 28, 2021-$1.50M–
Q1 FY2021CQ4 2020Nov 30, 2020-$1.32M–
Q4 FY2020CQ3 2020Aug 31, 2020-$872.33K–
Q3 FY2020CQ2 2020May 31, 2020-$1.02M–
Q2 FY2020CQ1 2020Feb 29, 2020-$1.40M–
Q1 FY2020CQ4 2019Nov 30, 2019-$1.05M–
Q4 FY2019CQ3 2019Aug 31, 2019-$1.06M–
Q3 FY2019CQ2 2019May 31, 2019-$589.45K–
Q2 FY2019CQ1 2019Feb 28, 2019-$740.97K–
Q1 FY2019CQ4 2018Nov 30, 2018-$401.15K–
Q4 FY2018CQ3 2018Aug 31, 2018-$513.87K–
Q3 FY2018CQ2 2018May 31, 2018-$458.77K–
Q2 FY2018CQ1 2018Feb 28, 2018-$467.49K–
Q1 FY2018CQ4 2017Nov 30, 2017-$169.89K–
Q4 FY2017CQ3 2017Aug 31, 2017-$157.96K–
Q3 FY2017CQ2 2017May 31, 2017-$36.67K–
Q2 FY2017CQ1 2017Feb 28, 2017-$9.79K–
Q1 FY2017CQ4 2016Nov 30, 2016-$12.41K–
Q4 FY2016CQ3 2016Aug 31, 2016$0–
Q3 FY2016CQ2 2016May 31, 2016-$3.85K–
Q2 FY2016CQ1 2016Feb 29, 2016-$381–
Q1 FY2016CQ4 2015Nov 30, 2015-$14.26K–
Q4 FY2015CQ3 2015Aug 31, 2015-$2.85K–
Q3 FY2015CQ2 2015May 31, 2015-$4.00K–

More Artelo Biosciences figures

See a number that looks wrong?